Endoscopic submucosal dissection (ESD) is a minimally invasive procedure widely regarded as the standard treatment for large superficial gastrointestinal neoplasms, including rectal laterally ...
'Underwater' endoscopic mucosal resection (UEMR) could eliminate the need for submucosal injection of large sessile colorectal polyps prior to resection. Submucosal injection before EMR is used to ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--EndoClot Plus, Inc. (EPI), a privately held medical device company announced the FDA 510(k) clearance of EndoClot ® Submucosal Injection Agent (EndoClot ® SIA) ...
The injection of fluid into the submucosal layer facilitates safer and easier removal of sessile polyps. The fluid lifts the polyp and increases the distance between the base of the polyp and the ...
Active ingredient: Dextranomer microspheres 50 mg/mL, sodium hyaluronate 15 mg/mL; gel for submucosal injection. Indication: Treatment of fecal incontinence in patients who have failed conservative ...
The Blue Eye submucosal injection agent has received FDA clearance and is now available in the U.S. The product, manufactured by Korean devicemaker the Standard Company, is used in endoscopic ...
"We are excited to expand our global partnership with EndoClot Plus, Inc. The addition of their solutions to our portfolio allows us to strengthen our commitment to our customers as a full ...
Dublin, April 08, 2026 (GLOBE NEWSWIRE)-- The "Endoscopic Submucosal Dissection Market Size, Share & Trends Analysis Report by Product, Indication, End Use, Region, and Segment Forecasts, 2026-2033" ...
Submucosal Injections market players – Bio Space Inc., GI Supply Cosmo Pharmaceuticals N.V., FUJIFILM Medical Systems, Medtronic Plc., Zeon Medical, among others represent the global Submucosal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results